John Johnson - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Portola Pharmaceuticals Inc (PTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Portola Pharmaceuticals Inc (PTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Portola Pharmaceuticals Inc (PTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Strongbridge Biopharma PLC (SBBP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Strongbridge Biopharma PLC (SBBP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Strongbridge Biopharma PLC (SBBP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John Johnson made no insider transaction in Verastem Inc (VSTM). Other recent insider transactions involving Verastem Inc (VSTM) include a net sale of 736 shares made by Daniel Calkins , a net sale of 20,890 shares made by Robert E. Gagnon , and a net sale of 6,617 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 2,682 shares of Verastem Inc (VSTM) in total and bought 0 shares, with a net sale of 2,682 shares. During the past 18 months, 33,359 shares of Verastem Inc (VSTM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 33,359 shares.

Verastem Inc (VSTM)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Melinta Therapeutics Inc (MLNTQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Melinta Therapeutics Inc (MLNTQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Melinta Therapeutics Inc (MLNTQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John Johnson made no insider transaction in Ocugen Inc (OCGN). Other recent insider transactions involving Ocugen Inc (OCGN) include a net purchase of 25,000 shares made by Kirsten Castillo , and a net purchase of 10,000 shares made by Prabhavathi Fernandes .

In summary, during the past 3 months, insiders sold 0 shares of Ocugen Inc (OCGN) in total and bought 35,000 shares, with a net purchase of 35,000 shares. During the past 18 months, 0 shares of Ocugen Inc (OCGN) were sold and 35,000 shares were bought by its insiders, resulting in a net purchase of 35,000 shares.

Ocugen Inc (OCGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sucampo Pharmaceuticals Inc (SCMP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sucampo Pharmaceuticals Inc (SCMP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sucampo Pharmaceuticals Inc (SCMP)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AVEO Pharmaceuticals Inc (AVEO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AVEO Pharmaceuticals Inc (AVEO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AVEO Pharmaceuticals Inc (AVEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Ocera Therapeutics Inc (OCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ocera Therapeutics Inc (OCRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ocera Therapeutics Inc (OCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John Johnson made no insider transaction in Eli Lilly and Co (LLY). Other recent insider transactions involving Eli Lilly and Co (LLY) include a net sale of 3,890,933 shares made by Lilly Endowment Inc , a net sale of 4,420 shares made by Donald A Zakrowski , and a net sale of 7,056 shares made by Johna Norton .

In summary, during the past 3 months, insiders sold 900 shares of Eli Lilly and Co (LLY) in total and bought 0 shares, with a net sale of 900 shares. During the past 18 months, 3,903,557 shares of Eli Lilly and Co (LLY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,903,557 shares.

Eli Lilly and Co (LLY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John Johnson made no insider transaction in Axogen Inc (AXGN). Other recent insider transactions involving Axogen Inc (AXGN) include a net sale of 42,343 shares made by Michael Patrick Donovan , a net sale of 39,280 shares made by Karen L. Zaderej , and a net sale of 25,000 shares made by Gregory Gene Freitag .

In summary, during the past 3 months, insiders sold 0 shares of Axogen Inc (AXGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 130,582 shares of Axogen Inc (AXGN) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 100,582 shares.

Axogen Inc (AXGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John Johnson made no insider transaction in Xeris Biopharma Holdings Inc (XERS). Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 25,200 shares made by John P. Schmid , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 104,779 shares were bought by its insiders, resulting in a net purchase of 104,779 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.